TGFB1 and neoplasm: TGFβ is normally a tumor-suppressive and anti-proliferative cytokine for epithelial tissues, and tumors therefore often show aberrant TGFβ signaling due to inactivating mutations in SMADs or TGFBR, or in genes that are downstream of TGFβ2,3,5.